These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Post-myocardial infarction beta-blocker therapy: the bradycardia conundrum. Rationale and design for the Pacemaker & beta-blocker therapy post-MI (PACE-MI) trial. Goldberger JJ; Bonow RO; Cuffe M; Dyer A; Greenland P; Rosenberg Y; O'Rourke R; Shah PK; Smith S Am Heart J; 2008 Mar; 155(3):455-64. PubMed ID: 18294477 [TBL] [Abstract][Full Text] [Related]
3. Profound symptomatic bradycardia associated with combined mibefradil and beta-blocker therapy. Rogers R; Prpic R Med J Aust; 1998 Oct; 169(8):425-7. PubMed ID: 9830391 [TBL] [Abstract][Full Text] [Related]
4. Glucagon treatment for bradycardia and a junctional rhythm caused by excessive beta-blockade. Bindon MJ; Barlotta K Resuscitation; 2009 Nov; 80(11):1327. PubMed ID: 19744763 [No Abstract] [Full Text] [Related]
5. Effects of atenolol as add-on therapy to fosinopril in heart failure. Pacher R; Hülsmann M; Berger R; Koller-Strametz J; Kos T; Frey B; Dukat A; Stanek B Wien Klin Wochenschr; 1997 Apr; 109(7):232-8. PubMed ID: 9141231 [TBL] [Abstract][Full Text] [Related]
6. Syncope and sinus bradycardia from combined use of thalidomide and beta-blocker. Yamaguchi T Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):1033-5. PubMed ID: 18613249 [TBL] [Abstract][Full Text] [Related]
7. [Every 2nd heart failure patient without beta blocker. "Intolerance" is often a dosage error]. MMW Fortschr Med; 2003 Feb; 145(6):58. PubMed ID: 12619366 [No Abstract] [Full Text] [Related]
8. [Therapy of chronic heart failure with beta-receptor blockers]. Böhm M Z Kardiol; 1996; 85 Suppl 7():11-21. PubMed ID: 9082679 [TBL] [Abstract][Full Text] [Related]
9. Which beta-blocker? Med Lett Drugs Ther; 2001 Feb; 43(1097):9-11. PubMed ID: 11177223 [No Abstract] [Full Text] [Related]
10. Beta-blocker target dosing and tolerability in a dedicated heart failure clinic in Johannesburg. Bolon J; McCutcheon K; Klug E; Smith D; Manga P Cardiovasc J Afr; 2019 Mar/Apr 23; 30(2):103-107. PubMed ID: 30740613 [TBL] [Abstract][Full Text] [Related]
11. Beta-blocker therapy in patients with heart failure in the urban setting: moving beyond clinical trials. Estep JD; Mehta SK; Uddin F; King L; Toto KH; Nelson LL; Dries DL; Yancy CW; Drazner MH Am Heart J; 2004 Dec; 148(6):958-63. PubMed ID: 15632878 [TBL] [Abstract][Full Text] [Related]
13. [Beta-blockers and non-cardiac surgery: benefit and risks]. Schaal JV; Pelée de Saint Maurice G; Boutonnet M; Cottez-Gacia S; Ausset S Ann Fr Anesth Reanim; 2009 Sep; 28(9):806-7; author reply 807-8. PubMed ID: 19651484 [No Abstract] [Full Text] [Related]
14. Drug induced bradycardia: to pace or not to pace? Ovsyshcher IE; Barold SS Pacing Clin Electrophysiol; 2004 Aug; 27(8):1144-7. PubMed ID: 15305965 [No Abstract] [Full Text] [Related]
15. Esmolol--a short-acting i.v. beta-blocker. Med Lett Drugs Ther; 1987 Jun; 29(742):57-8. PubMed ID: 2884558 [No Abstract] [Full Text] [Related]
17. [Therapy of heart failure with beta-blockers?]. Osterziel KJ; Dietz R Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118 [TBL] [Abstract][Full Text] [Related]
18. [Beta receptor blocker for therapy of chronic cardiac insufficiency. A vision of clinical pharmacology]. Schmidt BM; Wehling M; Ertl G Dtsch Med Wochenschr; 1998 Feb; 123(7):171-3. PubMed ID: 9505941 [No Abstract] [Full Text] [Related]